Abstract
A Phase II Study of a Paclitaxel Based Chemoradiation Regimen With Selective Surgical Salvage for Resectable Locoregionally Advanced Esophageal Cancer: Initial Reporting of RTOG 0246
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have